1034 related articles for article (PubMed ID: 9808873)
1. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
2. Platelet Activity in the Early Stage of Acute Myocardial Infarction: Relation to Time of Presentation, Treatment with Either Tissue Plasminogen Activator or Streptokinase and Cyclooxygenase Inhibition.
Salvioni A; Perego GB; Marenzi G; Galli S; Assanelli E; Guazzi MD
J Thromb Thrombolysis; 1998; 5(1):65-71. PubMed ID: 10608053
[TBL] [Abstract][Full Text] [Related]
3. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
[TBL] [Abstract][Full Text] [Related]
4. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
[TBL] [Abstract][Full Text] [Related]
5. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
[TBL] [Abstract][Full Text] [Related]
7. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
8. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
[TBL] [Abstract][Full Text] [Related]
9. [Effects of reperfusion and coronary reocclusion on the variability of heart rate in patients with acute myocardial infarction].
Pizzi C; Costa GM; Borghi A; Premuda G; Tondini C; Magri G; Cordioli E; Bugiardini R
Cardiologia; 1999 Feb; 44(2):181-6. PubMed ID: 10208055
[TBL] [Abstract][Full Text] [Related]
10. [Are ECG criteria for indications for thrombolysis in acute myocardial infarct defined too narrowly?].
Weiss P; Sarasin C; Ritz R; Pfisterer M
Schweiz Med Wochenschr; 1991 Dec; 121(49):1829-32. PubMed ID: 1754866
[TBL] [Abstract][Full Text] [Related]
11. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
Kobusiak-Prokopowicz M; Mysiak A
Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
[TBL] [Abstract][Full Text] [Related]
12. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
[TBL] [Abstract][Full Text] [Related]
13. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H
J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
[TBL] [Abstract][Full Text] [Related]
15. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction.
Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M
Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008
[TBL] [Abstract][Full Text] [Related]
16. Coronary thrombolysis with clot-selective plasminogen activators.
Collen D; Bounameaux H
Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
[TBL] [Abstract][Full Text] [Related]
17. [The study of the activity of creatine kinase in diagnosis of coronary reperfusion in patients with acute myocardial infarction after thrombolysis].
Mysiak A; Salomon P; Halawa B
Pol Merkur Lekarski; 1999 Aug; 7(38):58-60. PubMed ID: 10522418
[TBL] [Abstract][Full Text] [Related]
18. [Early evaluation of results from systemic thrombolysis in acute myocardial infarct: the value of troponin I].
Giraldi F; Grazi S; Guazzi MD
Cardiologia; 1998 May; 43(5):485-91. PubMed ID: 9701879
[TBL] [Abstract][Full Text] [Related]
19. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
[TBL] [Abstract][Full Text] [Related]
20. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
